BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 21767389)

  • 1. Allele-specific regulation of FGFR2 expression is cell type-dependent and may increase breast cancer risk through a paracrine stimulus involving FGF10.
    Huijts PE; van Dongen M; de Goeij MC; van Moolenbroek AJ; Blanken F; Vreeswijk MP; de Kruijf EM; Mesker WE; van Zwet EW; Tollenaar RA; Smit VT; van Asperen CJ; Devilee P
    Breast Cancer Res; 2011 Jul; 13(4):R72. PubMed ID: 21767389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional analysis of a breast cancer-associated FGFR2 single nucleotide polymorphism using zinc finger mediated genome editing.
    Robbez-Masson LJ; Bödör C; Jones JL; Hurst HC; Fitzgibbon J; Hart IR; Grose RP
    PLoS One; 2013; 8(11):e78839. PubMed ID: 24265722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A study on genetic variants of Fibroblast growth factor receptor 2 (FGFR2) and the risk of breast cancer from North India.
    Siddiqui S; Chattopadhyay S; Akhtar MS; Najm MZ; Deo SV; Shukla NK; Husain SA
    PLoS One; 2014; 9(10):e110426. PubMed ID: 25333473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of single nucleotide polymorphisms in FGF-RAS/MAP signalling cascade with breast cancer susceptibility.
    Dankova Z; Zubor P; Grendar M; Kapinova A; Zelinova K; Jagelkova M; Gondova A; Dokus K; Kalman M; Lasabova Z; Danko J
    Gen Physiol Biophys; 2017 Dec; 36(5):565-572. PubMed ID: 29372690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence that the 5p12 Variant rs10941679 Confers Susceptibility to Estrogen-Receptor-Positive Breast Cancer through FGF10 and MRPS30 Regulation.
    Ghoussaini M; French JD; Michailidou K; Nord S; Beesley J; Canisus S; Hillman KM; Kaufmann S; Sivakumaran H; Moradi Marjaneh M; Lee JS; Dennis J; Bolla MK; Wang Q; Dicks E; Milne RL; Hopper JL; Southey MC; Schmidt MK; Broeks A; Muir K; Lophatananon A; Fasching PA; Beckmann MW; Fletcher O; Johnson N; Sawyer EJ; Tomlinson I; Burwinkel B; Marme F; Guénel P; Truong T; Bojesen SE; Flyger H; Benitez J; González-Neira A; Alonso MR; Pita G; Neuhausen SL; Anton-Culver H; Brenner H; Arndt V; Meindl A; Schmutzler RK; Brauch H; Hamann U; Tessier DC; Vincent D; Nevanlinna H; Khan S; Matsuo K; Ito H; Dörk T; Bogdanova NV; Lindblom A; Margolin S; Mannermaa A; Kosma VM; ; Wu AH; Van Den Berg D; Lambrechts D; Floris G; Chang-Claude J; Rudolph A; Radice P; Barile M; Couch FJ; Hallberg E; Giles GG; Haiman CA; Le Marchand L; Goldberg MS; Teo SH; Yip CH; Borresen-Dale AL; ; Zheng W; Cai Q; Winqvist R; Pylkäs K; Andrulis IL; Devilee P; Tollenaar RA; García-Closas M; Figueroa J; Hall P; Czene K; Brand JS; Darabi H; Eriksson M; Hooning MJ; Koppert LB; Li J; Shu XO; Zheng Y; Cox A; Cross SS; Shah M; Rhenius V; Choi JY; Kang D; Hartman M; Chia KS; Kabisch M; Torres D; Luccarini C; Conroy DM; Jakubowska A; Lubinski J; Sangrajrang S; Brennan P; Olswold C; Slager S; Shen CY; Hou MF; Swerdlow A; Schoemaker MJ; Simard J; Pharoah PD; Kristensen V; Chenevix-Trench G; Easton DF; Dunning AM; Edwards SL
    Am J Hum Genet; 2016 Oct; 99(4):903-911. PubMed ID: 27640304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FGF8, FGF10 and FGF receptor 2 in foreskin of children with hypospadias: an analysis of immunohistochemical expression patterns and gene transcription.
    Haid B; Pechriggl E; Nägele F; Dudas J; Webersinke G; Rammer M; Fritsch H; Oswald J
    J Pediatr Urol; 2020 Feb; 16(1):41.e1-41.e10. PubMed ID: 31718875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between FGFR2 (rs2981582, rs2420946 and rs2981578) polymorphism and breast cancer susceptibility: a meta-analysis.
    Zhang Y; Zeng X; Liu P; Hong R; Lu H; Ji H; Lu L; Li Y
    Oncotarget; 2017 Jan; 8(2):3454-3470. PubMed ID: 27966449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FGF10/FGFR2 signal induces cell migration and invasion in pancreatic cancer.
    Nomura S; Yoshitomi H; Takano S; Shida T; Kobayashi S; Ohtsuka M; Kimura F; Shimizu H; Yoshidome H; Kato A; Miyazaki M
    Br J Cancer; 2008 Jul; 99(2):305-13. PubMed ID: 18594526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The breast cancer susceptibility gene product fibroblast growth factor receptor 2 serves as a scaffold for regulation of NF-κB signaling.
    Wei W; Liu W; Cassol CA; Zheng W; Asa SL; Ezzat S
    Mol Cell Biol; 2012 Nov; 32(22):4662-73. PubMed ID: 22988296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FGFR2 risk SNPs confer breast cancer risk by augmenting oestrogen responsiveness.
    Campbell TM; Castro MAA; de Santiago I; Fletcher MNC; Halim S; Prathalingam R; Ponder BAJ; Meyer KB
    Carcinogenesis; 2016 Aug; 37(8):741-750. PubMed ID: 27236187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between rs2981582 polymorphism in the FGFR2 gene and the risk of breast cancer in Mexican women.
    Murillo-Zamora E; Moreno-Macías H; Ziv E; Romieu I; Lazcano-Ponce E; Angeles-Llerenas A; Pérez-Rodríguez E; Vidal-Millán S; Fejerman L; Torres-Mejía G
    Arch Med Res; 2013 Aug; 44(6):459-66. PubMed ID: 24054997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic variants of fibroblast growth factor receptor 2 (FGFR2) are associated with breast cancer risk in Chinese women of the Han nationality.
    Chen F; Lu M; Xue Y; Zhou J; Hu F; Chen X; Zhao Z; Li Y; Wang X
    Immunogenetics; 2012 Jan; 64(1):71-6. PubMed ID: 21822685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FGFR2 variants and breast cancer risk: fine-scale mapping using African American studies and analysis of chromatin conformation.
    Udler MS; Meyer KB; Pooley KA; Karlins E; Struewing JP; Zhang J; Doody DR; MacArthur S; Tyrer J; Pharoah PD; Luben R; Bernstein L; Kolonel LN; Henderson BE; Le Marchand L; Ursin G; Press MF; Brennan P; Sangrajrang S; Gaborieau V; Odefrey F; Shen CY; Wu PE; Wang HC; Kang D; Yoo KY; Noh DY; Ahn SH; Ponder BA; Haiman CA; Malone KE; Dunning AM; Ostrander EA; Easton DF;
    Hum Mol Genet; 2009 May; 18(9):1692-703. PubMed ID: 19223389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FGF ligands of the postnatal mammary stroma regulate distinct aspects of epithelial morphogenesis.
    Zhang X; Martinez D; Koledova Z; Qiao G; Streuli CH; Lu P
    Development; 2014 Sep; 141(17):3352-62. PubMed ID: 25078648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibroblast growth factors 7 and 10 are involved in ameloblastoma proliferation via the mitogen-activated protein kinase pathway.
    Nakao Y; Mitsuyasu T; Kawano S; Nakamura N; Kanda S; Nakamura S
    Int J Oncol; 2013 Nov; 43(5):1377-84. PubMed ID: 24002438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of FGF10-ERK signal activation suppresses intraductal papillary neoplasm of the bile duct and its associated carcinomas.
    Tomita H; Tanaka K; Hirata A; Okada H; Imai H; Shirakami Y; Ohnishi K; Sugie S; Aoki H; Hatano Y; Noguchi K; Kanayama T; Niwa A; Suzui N; Miyazaki T; Tanaka T; Akiyama H; Shimizu M; Yoshida K; Hara A
    Cell Rep; 2021 Feb; 34(8):108772. PubMed ID: 33626352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of breast cancer susceptibility loci on 2q35, 3p24, 17q23 and FGFR2 genes in Taiwanese women with breast cancer.
    Lin CY; Ho CM; Bau DT; Yang SF; Liu SH; Lin PH; Lin TH; Tien N; Shih MC; Lu JJ
    Anticancer Res; 2012 Feb; 32(2):475-82. PubMed ID: 22287734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 2,3,7,8-Tetrachlorodibenzo-p-dioxin inhibits fibroblast growth factor 10-induced prostatic bud formation in mouse urogenital sinus.
    Vezina CM; Hardin HA; Moore RW; Allgeier SH; Peterson RE
    Toxicol Sci; 2010 Jan; 113(1):198-206. PubMed ID: 19805408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA damage to bone marrow stromal cells by antileukemia drugs induces chemoresistance in acute myeloid leukemia via paracrine FGF10-FGFR2 signaling.
    Yu S; Ye J; Wang Y; Lu T; Liu Y; Liu N; Zhang J; Lu F; Ma D; Gale RP; Ji C
    J Biol Chem; 2023 Jan; 299(1):102787. PubMed ID: 36509141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fine-scale mapping of the FGFR2 breast cancer risk locus: putative functional variants differentially bind FOXA1 and E2F1.
    Meyer KB; O'Reilly M; Michailidou K; Carlebur S; Edwards SL; French JD; Prathalingham R; Dennis J; Bolla MK; Wang Q; de Santiago I; Hopper JL; Tsimiklis H; Apicella C; Southey MC; Schmidt MK; Broeks A; Van 't Veer LJ; Hogervorst FB; Muir K; Lophatananon A; Stewart-Brown S; Siriwanarangsan P; Fasching PA; Lux MP; Ekici AB; Beckmann MW; Peto J; Dos Santos Silva I; Fletcher O; Johnson N; Sawyer EJ; Tomlinson I; Kerin MJ; Miller N; Marme F; Schneeweiss A; Sohn C; Burwinkel B; Guénel P; Truong T; Laurent-Puig P; Menegaux F; Bojesen SE; Nordestgaard BG; Nielsen SF; Flyger H; Milne RL; Zamora MP; Arias JI; Benitez J; Neuhausen S; Anton-Culver H; Ziogas A; Dur CC; Brenner H; Müller H; Arndt V; Stegmaier C; Meindl A; Schmutzler RK; Engel C; Ditsch N; Brauch H; Brüning T; Ko YD; ; Nevanlinna H; Muranen TA; Aittomäki K; Blomqvist C; Matsuo K; Ito H; Iwata H; Yatabe Y; Dörk T; Helbig S; Bogdanova NV; Lindblom A; Margolin S; Mannermaa A; Kataja V; Kosma VM; Hartikainen JM; Chenevix-Trench G; ; ; Wu AH; Tseng CC; Van Den Berg D; Stram DO; Lambrechts D; Thienpont B; Christiaens MR; Smeets A; Chang-Claude J; Rudolph A; Seibold P; Flesch-Janys D; Radice P; Peterlongo P; Bonanni B; Bernard L; Couch FJ; Olson JE; Wang X; Purrington K; Giles GG; Severi G; Baglietto L; McLean C; Haiman CA; Henderson BE; Schumacher F; Le Marchand L; Simard J; Goldberg MS; Labrèche F; Dumont M; Teo SH; Yip CH; Phuah SY; Kristensen V; Grenaker Alnæs G; Børresen-Dale AL; Zheng W; Deming-Halverson S; Shrubsole M; Long J; Winqvist R; Pylkäs K; Jukkola-Vuorinen A; Kauppila S; Andrulis IL; Knight JA; Glendon G; Tchatchou S; Devilee P; Tollenaar RA; Seynaeve CM; García-Closas M; Figueroa J; Chanock SJ; Lissowska J; Czene K; Darabi H; Eriksson K; Hooning MJ; Martens JW; van den Ouweland AM; van Deurzen CH; Hall P; Li J; Liu J; Humphreys K; Shu XO; Lu W; Gao YT; Cai H; Cox A; Reed MW; Blot W; Signorello LB; Cai Q; Pharoah PD; Ghoussaini M; Harrington P; Tyrer J; Kang D; Choi JY; Park SK; Noh DY; Hartman M; Hui M; Lim WY; Buhari SA; Hamann U; Försti A; Rüdiger T; Ulmer HU; Jakubowska A; Lubinski J; Jaworska K; Durda K; Sangrajrang S; Gaborieau V; Brennan P; McKay J; Vachon C; Slager S; Fostira F; Pilarski R; Shen CY; Hsiung CN; Wu PE; Hou MF; Swerdlow A; Ashworth A; Orr N; Schoemaker MJ; Ponder BA; Dunning AM; Easton DF
    Am J Hum Genet; 2013 Dec; 93(6):1046-60. PubMed ID: 24290378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.